Physical inactivity and the economic and health burdens due to cardiovascular disease: Exercise as medicine

Mark Hamer, Gary O’Donovan, Marie Murphy

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

16 Scopus citations

Abstract

Leisure time physical activity, or exercise, has been described as today’s best buy in public health. Physical inactivity is responsible for around 10% of all deaths and physical inactivity costs global healthcare systems billions of dollars each year. Here, we describe the human and economic costs of cardiovascular disease. Then, we explain that physical inactivity is a major modifiable risk factor for cardiovascular disease. The evidence of the role of physical activity in the primary prevention of cardiovascular disease is reviewed and we make the case that exercise is medicine.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages3-18
Number of pages16
DOIs
StatePublished - 2017
Externally publishedYes

Publication series

NameAdvances in Experimental Medicine and Biology
Volume999
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Keywords

  • Cardiovascular disease
  • Exercise
  • Medicine
  • Prevalence

Fingerprint

Dive into the research topics of 'Physical inactivity and the economic and health burdens due to cardiovascular disease: Exercise as medicine'. Together they form a unique fingerprint.

Cite this